Verified peer comparison
4D Molecular Therapeutics vs National Bankshares Financial Comparison
Direct answer
4D Molecular Therapeutics and National Bankshares are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free 4D Molecular Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- 4D Molecular Therapeutics Revenue
- 85,209,000 USD
- National Bankshares Revenue
- 85,315,000 USD
- 4D Molecular Therapeutics Operating income
- -159,547,000 USD
- National Bankshares Operating income
- 19,166,000 USD